The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical activity of SL-801, a reversible inhibitor of Exportin-1 (XPO1)/Chromosome Region Maintenance-1 (CRM1) in solid and hematologic cancers.
 
Janice Chen
Employment - Stemline Therapeutics
Stock and Other Ownership Interests - Stemline Therapeutics
 
Christopher L. Brooks
Employment - Stemline Therapeutics
Stock and Other Ownership Interests - Stemline Therapeutics
Patents, Royalties, Other Intellectual Property - Stemline Therapeutics
 
Peter McDonald
Employment - Stemline Therapeutics
Stock and Other Ownership Interests - Stemline Therapeutics
 
Jonathan D. Schwartz
Employment - Stemline Therapeutics
Leadership - Stemline Therapeutics
Stock and Other Ownership Interests - Stemline Therapeutics
 
Keiichi Sakakibara
Employment - CanBas
Stock and Other Ownership Interests - CanBas
 
Naoya Saito
Employment - CanBas
Stock and Other Ownership Interests - CanBas
 
Takuji Sato
Employment - CanBas
Stock and Other Ownership Interests - CanBas
Patents, Royalties, Other Intellectual Property - CanBas
 
Takumi Kawabe
Employment - CanBas
Leadership - CanBas
Stock and Other Ownership Interests - CanBas
Patents, Royalties, Other Intellectual Property - CanBas
 
Eric Keith Rowinsky
Employment - Stemline Therapeutics
Leadership - Biogen
Stock and Other Ownership Interests - Stemline Therapeutics